Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline Update Q and A

被引：3
|
作者：
Clark, Amy S. [1 ]
Cobain, Erin F. [2 ]
Dayao, Zoneddy [3 ]
Somerfield, Mark R. [4 ]
DeMichele, Angela [1 ]
Henry, N. Lynn [2 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
[2] Univ Michigan, Ann Arbor, MI 48109 USA
[3] Univ New Mexico Hosp, Albuquerque, NM USA
[4] Amer Soc Clin Oncol, 2318 Mill Rd,Ste 800, Alexandria, VA 22314 USA
来源：
JCO ONCOLOGY PRACTICE | 2022年 / 18卷 / 12期
关键词：
D O I：
10.1200/OP.22.00506
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：830 / +
页数：4
相关论文
共 50 条
  • [1] Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline Update
    Henry, N. Lynn
    Somerfield, Mark R.
    Dayao, Zoneddy
    Elias, Anthony
    Kalinsky, Kevin
    McShane, Lisa M.
    Moy, Beverly
    Park, Ben Ho
    Shanahan, Kelly M.
    Sharma, Priyanka
    Shatsky, Rebecca
    Stringer-Reasor, Erica
    Telli, Melinda
    Turner, Nicholas C.
    DeMichele, Angela
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (27) : 3205 - +
  • [2] Systemic Therapy for Melanoma: ASCO Guideline Update Q and A
    Sondak, Vernon K.
    Atkins, Michael B.
    Messersmith, Hans
    Provenzano, Anthony
    Seth, Rahul
    Agarwala, Sanjiv S.
    [J]. JCO ONCOLOGY PRACTICE, 2024, 20 (02)
  • [3] Systemic Treatment of Patients With Metastatic Breast Cancer: ASCO Resource-Stratified Guideline Q and A
    Al Sukhun, Sana
    Koczwara, Bogda
    Temin, Sarah
    Arun, Banu K.
    [J]. JCO GLOBAL ONCOLOGY, 2024, 10
  • [4] Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update: ASCO Guideline Q and A
    Virgo, Katherine S.
    Rumble, R. Bryan
    Talcott, James A.
    [J]. JCO ONCOLOGY PRACTICE, 2023, 19 (10)
  • [5] Systemic Therapy for Melanoma: ASCO Guideline Update
    Seth, Rahul
    Agarwala, Sanjiv S.
    Messersmith, Hans
    Alluri, Krishna C.
    Ascierto, Paolo A.
    Atkins, Michael B.
    Bollin, Kathryn
    Chacon, Matias
    Davis, Nancy
    Faries, Mark B.
    Funchain, Pauline
    Gold, Jason S.
    Guild, Samantha
    Gyorki, David E.
    Kaur, Varinder
    Khushalani, Nikhil I.
    Kirkwood, John M.
    McQuade, Jennifer Leigh
    Meyers, Michael O.
    Provenzano, Anthony
    Robert, Caroline
    Santinami, Mario
    Sehdev, Amikar
    Sondak, Vernon K.
    Spurrier, Gilliosa
    Swami, Umang
    Truong, Thach-Giao
    Tsai, Katy K.
    van Akkooi, Alexander
    Weber, Jeffrey
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (30) : 4794 - +
  • [6] Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline Update Q and A
    Raab, Rachel
    Ismaila, Nofisat
    Andre, Fabrice
    Stearns, Vered
    Kalinsky, Kevin
    [J]. JCO ONCOLOGY PRACTICE, 2022, 18 (09) : 646 - +
  • [7] Metastatic Pancreatic Cancer: ASCO Guideline Update
    Sohal, Davendra P. S.
    Kennedy, Erin B.
    Cinar, Pelin
    Conroy, Thierry
    Copur, Mehmet S.
    Crane, Christopher H.
    Garrido-Laguna, Ignacio
    Lau, Michelle W.
    Johnson, Tyler
    Krishnamurthi, Smitha
    Moravek, Cassadie
    O'Reilly, Eileen M.
    Philip, Philip A.
    Pant, Shubham
    Shah, Manish A.
    Sahai, Vaibhav
    Uronis, Hope E.
    Zaidi, Neeha
    Laheru, Daniel
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (27) : 3217 - +
  • [8] Systemic Therapy for Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Guideline Update Q and A
    Crews, Jennie R.
    Kirshner, Jeffrey J.
    Temin, Sarah
    [J]. JCO ONCOLOGY PRACTICE, 2022, 18 (11) : 753 - +
  • [9] Systemic Therapy Update on 177Lutetium-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline Rapid Recommendation Q and A
    Garje, Rohan
    Hope, Thomas A.
    Rumble, R. Bryan
    Parikh, Rahul A.
    [J]. JCO ONCOLOGY PRACTICE, 2023, 19 (03) : 132 - +
  • [10] Recent ASCO Guideline on the Use of Biomarkers for Adjuvant Systemic Therapy in Early-Stage Invasive Breast Cancer
    Copur, Mehmet S.
    Ramaekers, Ryan
    Gauchan, Dron
    Norvell, Max
    Clark, Douglas
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (32) : 3943 - +
12345